Cabot Wealth Management Inc. Purchases 14,491 Shares of Danaher Co. (NYSE:DHR)

Cabot Wealth Management Inc. increased its holdings in Danaher Co. (NYSE:DHR) by 53.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,595 shares of the conglomerate’s stock after acquiring an additional 14,491 shares during the quarter. Cabot Wealth Management Inc.’s holdings in Danaher were worth $9,548,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. AMF Tjanstepension AB purchased a new stake in shares of Danaher during the third quarter valued at $5,923,000. Howard Capital Management Group LLC lifted its stake in Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 48 shares during the period. Foundations Investment Advisors LLC boosted its holdings in shares of Danaher by 5.3% during the 3rd quarter. Foundations Investment Advisors LLC now owns 1,637 shares of the conglomerate’s stock valued at $455,000 after acquiring an additional 82 shares during the last quarter. International Assets Investment Management LLC grew its stake in shares of Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after acquiring an additional 428,897 shares during the period. Finally, Dakota Wealth Management raised its holdings in shares of Danaher by 1.0% during the third quarter. Dakota Wealth Management now owns 8,161 shares of the conglomerate’s stock valued at $2,269,000 after purchasing an additional 82 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Up 0.9 %

DHR stock opened at $209.86 on Friday. The company has a market capitalization of $151.58 billion, a price-to-earnings ratio of 39.75, a PEG ratio of 2.66 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1-year low of $196.80 and a 1-year high of $281.70. The business has a 50 day simple moving average of $226.71 and a two-hundred day simple moving average of $246.96.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business earned $2.09 earnings per share. Research analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. Danaher’s payout ratio is presently 20.45%.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on DHR. Scotiabank began coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a report on Friday, December 13th. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday, October 31st. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.